1. Home
  2. OSIS vs LGND Comparison

OSIS vs LGND Comparison

Compare OSIS & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OSI Systems Inc. (DE)

OSIS

OSI Systems Inc. (DE)

HOLD

Current Price

$204.47

Market Cap

3.8B

Sector

Technology

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$285.03

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSIS
LGND
Founded
1987
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.7B
IPO Year
1997
1997

Fundamental Metrics

Financial Performance
Metric
OSIS
LGND
Price
$204.47
$285.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
7
Target Price
$302.83
$256.29
AVG Volume (30 Days)
231.4K
200.4K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
2.76
2886.36
EPS
8.95
1.63
Revenue
$1,089,286,000.00
$141,102,000.00
Revenue This Year
$9.74
$1.25
Revenue Next Year
$5.53
$19.41
P/E Ratio
$22.80
$171.89
Revenue Growth
13.35
29.48
52 Week Low
$186.50
$158.52
52 Week High
$311.72
$326.63

Technical Indicators

Market Signals
Indicator
OSIS
LGND
Relative Strength Index (RSI) 37.97 46.17
Support Level $204.34 $181.43
Resistance Level $227.72 $322.06
Average True Range (ATR) 8.18 9.65
MACD -3.09 -1.43
Stochastic Oscillator 39.47 17.33

Price Performance

Historical Comparison
OSIS
LGND

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems, and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. The majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East and Africa, and the Asia Pacific regions.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: